BWX Technologies (BWXT) Stock Forecast & Price Target

BWX Technologies is favored because its backlog has more than doubled since year-end 2023 to $8.4B as of 2Q26, with 1.7x trailing-twelve-month book-to-bill and about 73% backlog coverage over the next six quarters, giving strong multi-year revenue visibility. Its sole-source role supplying nuclear reactor components and fuel to the U.S. Navy, plus a 30-year shipbuilding plan that supports 4%–6% long-term growth from existing platforms, creates durable government demand, while special materials contracts and advanced nuclear programs add further upside. Commercial Operations is also scaling rapidly, with revenue rising from about $330M in 2020 to more than $1.1B in 2026 and a $1.6B commercial backlog, supporting management’s 2026 guidance of roughly $3.80B revenue, $662M–$672M adjusted EBITDA, and $345M–$360M free cash flow.

BWX Technologies is viewed with a negative-to-neutral outlook because its current valuation appears to already reflect optimistic assumptions about future upside from emerging mobile nuclear reactor and medical isotope opportunities. While its Government Operations franchise is considered predictable and supported by rising DoD/DoE spending and bipartisan backing for a larger U.S. Navy fleet, the company still faces execution risk if adoption or timing in these new growth markets disappoints. The 2026 guidance was reiterated and a 2027 framework introduced, but that visibility is offset by concern that expectations for the broader nuclear value-chain expansion may be too elevated.